CBAYUSD
Cymabay Therapeutics Inc
Clinical-stage biopharmaceutical company developing therapies for chronic liver and metabolic diseases including seladelpar for primary biliary cholangitis
CUSIP: 23257D103HealthcareUS1 holder
Total Value
$5.06M
Total Shares
377.2K
Net Share Change
+97.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Leon Cooperman
$5.06M377.2K shares
ADD+97.2K(+34.7%)